A pilot study to determine the safety of recovered blood intended for auto- transfusion during pancreatic cancer operations
Prospective protocol assessing the safety of autologous blood transfusions following pancreatectomy for pancreatic ductal adenocarcinoma (PDAC)
Are you Eligible? (Inclusion Criteria)
Inclusion
Over 18 years of age undergoing open operation for biopsy confirmed pancreatic cancer
Exclusion
Past medical history of other primary non-skin malignancy, or history of Hepatitis B, C or HIV infection or high risk behaviors and unwilling to be tested
Specialty Area(s)
Pancreas
Trial Location
Columbia University Medical Center
HIP (The Herbert Irving Pavilion)
8th Floor
New York, NY 10032
United States